ACTICOAT^◊ Antimicrobial Barrier Dressings

A unique construction featuring nanocrystalline silver (NCS) technology delivers a sustained antimicrobial action for up to 7 days on acute, chronic and burn wounds^*1-4

Act with certainty

A large surface area of NCS structure enables sustained release of silver into the wound fluid, while the dressing helps to promote and retain a moist environment, when used with an appropriate secondary dressing. Shown to deliver sufficient silver at a consistent concentration to remain bactericidal.^**4-12

Product feature

Application

Evidence and Case Studies

Related technologies

Medical Education

No results.

Bestellinformationen

Artikelnr.	Größe	PZN	Inhalt/ Versandeinheit	Inhalt/Original- packung (OP)
66000808	5 cm x 5 cm	01675562	100 Stück (20 OP)	5 Stück
66000789	10 cm x 10 cm	02760703	50 Stück (10 OP)	5 Stück
66000791	10 cm x 10 cm	01885650	240 Stück (20 OP)	12 Stück
66000792	10 cm x 20 cm	01885667	240 Stück (20 OP)	12 Stück
66000793	20 cm x 40 cm	01885710	120 Stück (20 OP)	6 Stück
66000794	40 cm x 40 cm	01885727	30 Stück (5 OP)	6 Stück
66000795	10 cm x 120 cm	01885733	24 Stück (4 OP)	6 Stück

Erstattungsfähig

Artikelnr.	Größe	PZN	Inhalt/ Versandeinheit	Inhalt/Original- packung (OP)
66000809	5 cm x 5 cm	01675533	100 Stück (20 OP)	5 Stück
66000796	10 cm x 12,5 cm	01885756	50 Stück (10 OP)	5 Stück
66000797	15 cm x 15 cm	01885762	50 Stück (10 OP)	5 Stück

Erstattungsfähig

Disclaimer

^*Depending on dressing selection. ACTICOAT Dressing offers up to 3 days’ use. ACTICOAT 7 Dressing offers up to 7 days’ use.

^**As demonstrated in vitro.

Citations

1. Smith+Nephew 2008. Internal report. DS/08/062/R1.

2. Smith+Nephew 2009. Internal report. DS/08/078/R2.

3. Smith+Nephew 2008. Internal report. DS/08/062/R2.

4. Smith+Nephew 2017. Internal report. DS/16/363/R2.

5. Smith+Nephew 2008. Internal report. DOF 0810016.

6. Smith+Nephew 2008. Internal report. DOF 0810017.

7. Smith+Nephew 2008. Internal report. DOF 0810012.

8. Smith+Nephew 2008. Internal report. DOF 0810013.

9. Smith+Nephew. A 17-Day wound healing study in full-thickness wounds in minipigs. Internal Statement.

10. Wright JB, et al. Am J Infect Control. 1998;26(6):572 - 577.

11. Wright JB, et al. Am J Infect Control. 1999;27(4):344 - 350.

12. Westaim Biomedical 2001. Internal report - 971030.

13. Cuttle L, et al. Burns. 2007;33(6):701 - 707.

14. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.001.v2.

15. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.002.v2.

16. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.003.v2.

17. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.004.v2.

18. Gago M, et al. Wounds. 2008;20(10):273 - 278.

19. Demling RH, et al. Burns. 2002;28(3):264 - 266

20. Smith+Nephew 2008. Internal report. DOF 0810018.

21. Smith+Nephew 2008. Internal report. DOF 0810014.

22. Yin HQ, et al. J Burn Care Rehabil. 1999;20(3):195 - 200.

23. Wright JB, et al. Wounds. 1998;10(6):179 - 188.

24. Tredget EE, et al. J Burn Care Rehabil. 1998;19(6):531 - 537.

25. Strohal R, et al. J Hosp Infect. 2005;60(3):226 - 230.

26. Chaloner D, et al Paper presented at: WUWHS; 2004; Paris.

27. Westaim Biomedical 2000. Internal report - 001213.

28. Westaim Biomedical 2001. Internal report - 010322.

29. Glik J, et al. Int Wound J. 2018;15(3):344 - 349.